Clinical Trials Logo

Infant Development clinical trials

View clinical trials related to Infant Development.

Filter by:

NCT ID: NCT03434457 Completed - Infant Development Clinical Trials

Maternal Adversity, Vulnerability and Neurodevelopment

MAVAN
Start date: October 1, 2003
Phase:
Study type: Observational

Maternal Adversity Vulnerability and Neurodevelopment (MAVAN) project is a prospective community-based, pregnancy and birth cohort of Canadian mother-child dyads. The main objective of MAVAN project is to examine the pre- and postnatal influences, and their interaction, in determining individual differences in children development. The MAVAN project is designed to examine the consequences of fetal adversity as a function of the quality of the postnatal environment, focusing on mother-infant interactions.

NCT ID: NCT03405181 Completed - Infant Development Clinical Trials

Effects of the Additional Weight on the Reaching Behavior of Pre Term Infants With Low Birth Weight

Start date: January 12, 2018
Phase: N/A
Study type: Interventional

The effects of additional weight on early motor skills of infants have been increasingly studied. During the reaching behavior, the additional weight has been shown benefits in certain kinematic variables in full term and preterm infants. There is a growing interest in the study of populations at risk for motor development, especially considering interventions based on functional activities with the purpose of improving the neuromotor control, functional capacity and muscle strength. The aim of the present study is to investigate the effect of a functional training with additional weight in the reaching behavior of preterm infants with low birth weight and to compare the effects with a full term population. A controlled and randomized trial will be carried out with full term infants of adequate birth weight and preterm infants with low birth weight at 6 months of chronological or corrected age. The participants will be recruited by convenience from the charts of a Public Hospital. Participants will be randomly allocated into four groups: 1) adequate weight placebo group (AWPG); 2) adequate weight intervention group (AWIG); 2) low weight placebo group (LWPG) and 4) low weight intervention group (LWIG). . The assessor will be blinded (no knowledge of groups allocation). All infants will undergo a training program of eight sessions (2x/week; 4 weeks). The AWIG and LWIG will receive the training with an additional weight (characterized by a bracelet with a weight of 20% of the mass of the upper limbs)and the AWPG and LWPG will receive the same training, however, without the additional weight (only the bracelets).. All infants will be assessed in three different moments: 1) Pre-intervention: baseline, before the start of the intervention program; 2) Post-intervention: evaluation performed after the end of the program; and 3) Follow-up: evaluation performed seven days after the post-intervention assessment. The following kinematic dependent variables will be calculated: straightness index, mean velocity and motion units and electromyographic variables: pattern of activation and recruitment of muscle fibers - Biceps brachialis, Triceps brachialis, Deltoid and Pectoralis Major muscles; co-activation between biceps and triceps. The Qualisys Track Manager (QTM) and a wireless surface electromyography with 8-channels will be used. If normality assumptions are met, a mixed 2X2 ANOVA with repeated measures will be applied, in order to verify differences between the intervention programs, considering the dependent variables. Otherwise, non-parametric procedures of the same nature will be adopted. The significance will be set at 5% (P<0.05).

NCT ID: NCT03357458 Completed - Preterm Birth Clinical Trials

Parent-child Interactions, Child Developmental Health, and Health System Costs at 6 Months Corrected Age

Start date: January 22, 2018
Phase: N/A
Study type: Interventional

The aim of this novel health services research proposal is to assess the longer-term outcomes, to 6 months corrected age, of an adapted Family Integrated Care (FICare) model of care for moderate and late preterm infants admitted to a Level II neonatal intensive care unit (NICU). This follow-up study will enroll infants at 6 months CA (± 1 month) recruited to the original FICare randomized controlled trial (clinicaltrials.gov ID: NCT02879799) from four level II NICU sites; two intervention and two control.

NCT ID: NCT03331276 Completed - Infant Development Clinical Trials

Growth and Safety Study of an Infant Formula for Healthy Term Infants

Start date: September 18, 2017
Phase: N/A
Study type: Interventional

A goal of infant formula development is to mimic human milk (HM) both in nutrient composition as well as physiologic outcomes. investigators have developed an infant formula for term infants that more closely resembles the composition of human milk. The purpose of this study is to demonstrate that this formulation meets nutritional requirements and supports age appropriate growth of healthy term infants.

NCT ID: NCT03320837 Completed - Infant Development Clinical Trials

Metabolomic Profile of Urine Samples From Neonates Fed With Breast Milk and an Infant Formula Enriched With Synbiotics

mtburnIFsynb
Start date: August 1, 2017
Phase:
Study type: Observational

The aim of this trial is to verify - based on metabolomics and other anthropometric parameters - whether exclusive nutrition of infant formula enriched with synbiotics (probiotics B.lactis and prebiotics FOS), Long-Chain Polyunsaturated Fatty Acids (AA, DHA) and nucleotides, is comparable to breast milk and to mixed nutrition including breast milk together with the enriched infant formula.

NCT ID: NCT03297801 Completed - Clinical trials for Microbial Colonization

The Effects of Omega-3 PUFAs on the Infant Microbiome and Immunity

Start date: January 22, 2014
Phase:
Study type: Observational

Prenatal supplementation with fish oil, rich in omega-3 polyunsaturated fatty acids, is widely recommended in Canada. The aim of this observational, prospective cohort study is to determine the effects of maternal fish oil supplements on the development of their infants' gut microbiota and immunity.

NCT ID: NCT03271723 Completed - Physical Activity Clinical Trials

The 2015 Pelotas (Brazil) Birth Cohort Study

Start date: April 15, 2014
Phase: N/A
Study type: Observational

This is the fourth birth cohort to be carried out in the city of Pelotas (Brazil) including more than 4 thousand children followed-up since the pre-natal period to study maternal-child health.

NCT ID: NCT03236194 Completed - Infant Development Clinical Trials

Ancillary Microbiome Collection From Mother/Infant Pairs During First Year of Life

Start date: July 17, 2017
Phase:
Study type: Observational

The investigators will be studying the development of the microbiome over the first year after birth in light of various environmental influences - e.g. mode of delivery, diet (and diet changes), antibiotic exposure, GERD medication exposure.

NCT ID: NCT03230032 Completed - Thrombosis Clinical Trials

Pacifier Activated Device and Mother's Voice in Infants at High-risk for Cerebral Palsy

Start date: June 9, 2017
Phase: N/A
Study type: Interventional

The study seeks to determine the efficacy of non-nutritive suck (NNS) training using a pacifier-activated device (PAM) with mothers' voice to condition suck-strength and rhythmicity, in improving the feeding and developmental outcomes of infants at high-risk for CP.

NCT ID: NCT03111927 Completed - Healthy Clinical Trials

Infant Nutrition and Brain Development

Start date: March 13, 2017
Phase: N/A
Study type: Interventional

Research study on the role of early life nutrition on brain and cognitive development during infancy and early childhood. Two blends of myelin-relevant nutrients at different levels were compared and a breastfed group was considered as epidemiological reference.